Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | NM6603 |
| Synonyms | |
| Therapy Description |
NM6603 is a small molecule targeting retinoid X receptor alpha (RXRA), which potentially inhibits TGFbeta signaling, reduces immunosuppression, and decreases tumor cell proliferation (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| NM6603 | NM 6603|NM-6603 | NM6603 is a small molecule targeting retinoid X receptor alpha (RXRA), which potentially inhibits TGFbeta signaling, reduces immunosuppression, and decreases tumor cell proliferation (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06046066 | Phase I | NM6603 | A Phase 1 Study of NM6603 in Advanced Solid Tumors | Recruiting | USA | 0 |